RxDoctor Payments Data

Veronica Crawley, NP

Family · Gallatin, TNNPI 1922366442

Payments from drug & device makers

$14,673in general payments, 2019–2025

Across 884 payments — averaging $16.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • AbbVie$2K
  • AstraZeneca$1K
  • GSK$1K
  • Amgen$997
  • Lilly USA, LLC$845
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$14,607100%
  • Education$660%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk153$2,567
AbbVie151$1,660
AstraZeneca(2 entities)54$1,410
GSK63$1,227
Amgen62$997
Lilly USA, LLC67$845
Pfizer38$595
Boehringer Ingelheim33$570
Johnson & Johnson21$393
Astellas Pharma US Inc19$353
Otsuka America Pharmaceutical, Inc.14$283
Bayer14$261
Esperion Therapeutics, Inc.12$229
Dexcom, Inc.10$224
Exact Sciences12$196
Corcept Therapeutics8$170
Biohaven Pharmaceutical Holding Company Ltd.9$163
Shield Therapeutics Inc7$155
Amarin Pharma, Inc.10$153
Bausch Health US, LLC7$139
Aimmune Therapeutics, Inc.7$130
Sanofi-aventis U.S. LLC7$113
Sumitomo Pharma America, Inc.8$113
Takeda Pharmaceuticals U.S.A., Inc.7$110
Teva Pharmaceuticals USA, Inc.6$109
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$97
Novartis5$95
Biohaven Pharmaceuticals, Inc.4$94
Phathom Pharmaceuticals, Inc.8$91
Azurity Pharmaceuticals, Inc.4$77
Lundbeck LLC3$69
Amneal Pharmaceuticals LLC4$64
Xeris Pharmaceuticals, Inc.3$60
Jazz Pharmaceuticals Inc.3$56
Harmony Biosciences LLC2$47
Cequr Corporation2$45
Corium, LLC4$44
UCB, Inc.1$43
Idorsia Pharmaceuticals US Inc3$40
Phadia US Inc.2$37
Nestle Healthcare Nutrition Inc.2$37
Antares Pharma, Inc.2$35
Kowa Pharmaceuticals America, Inc.2$35
Ascensia Diabetes Care US Inc.2$34
Inspire Medical Systems, Inc.1$34
Adlon Therapeutics L.p.2$31
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$31
Eisai Inc.2$25
Boston Scientific1$24
BETA Bionics, Inc.1$23
Tris Pharma Inc1$22
Merz North America, Inc.1$20
Sunovion Pharmaceuticals Inc.2$19
Biomarin Pharmaceutical Inc.1$19
Insulet Corporation1$18
Halozyme Inc1$17
Tandem Diabetes Care, Inc.1$16
Medtronic1$16
Arbor Pharmaceuticals, Inc.1$15
Cranial Technologies, Inc1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,673 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$37,795
Medicare patients
153
Services billed
648

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide87$125,612
MounjaroTirzepatide64$86,116
JardianceEmpagliflozin59$76,058
FarxigaDapagliflozin Propanediol39$50,045
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$38,012
RybelsusSemaglutide17$33,759
TrulicityDulaglutide21$33,644
XareltoRivaroxaban14$20,466
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$18,737
GemtesaVibegron13$9,730
Bupropion XlBupropion Hcl36$2,927
Rosuvastatin Calcium216$2,875
ValacyclovirValacyclovir Hcl34$2,872
Atorvastatin Calcium201$2,637
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide39$1,569

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$2,567$159,372104 claims
Lilly USA, LLCMounjaro, Trulicity$845$119,75985 claims
Boehringer IngelheimJardiance$570$76,05859 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,410$68,78261 claims
GSKTrelegy Ellipta$1,227$38,01222 claims
Johnson & JohnsonXarelto$393$20,46614 claims
Sumitomo Pharma America, Inc.Gemtesa$113$9,73013 claims
AbbVieSynthroid$1,660$1,34718 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$64$1,185145 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,706 family providers in Tennessee.

Other family in Gallatin

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →